Pular para o conteúdo
Merck
Todas as fotos(1)

Documentos

M-012

Supelco

(±)-MDA solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Sinônimo(s):

(±)-3,4-Methylenedioxyamphetamine

Faça loginpara ver os preços organizacionais e de contrato


About This Item

Fórmula empírica (Notação de Hill):
C10H13NO2
Número CAS:
Peso molecular:
179.22
Número MDL:
Código UNSPSC:
41116107
ID de substância PubChem:
NACRES:
NA.24

grau

certified reference material

Nível de qualidade

forma

liquid

Características

Snap-N-Spike®/Snap-N-Shoot®

embalagem

ampule of 1 mL

fabricante/nome comercial

Cerilliant®

drug control

Narcotic Licence Schedule D (Switzerland); psicótropo (Spain); Decreto Lei 15/93: Tabela IIA (Portugal)

concentração

1.0 mg/mL in methanol

técnica(s)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

aplicação(ões)

forensics and toxicology

formato

single component solution

temperatura de armazenamento

−20°C

cadeia de caracteres SMILES

NC(C)CC1=CC=C(OCO2)C2=C1

InChI

1S/C10H13NO2/c1-7(11)4-8-2-3-9-10(5-8)13-6-12-9/h2-3,5,7H,4,6,11H2,1H3

chave InChI

NGBBVGZWCFBOGO-UHFFFAOYSA-N

Descrição geral

A certified solution standard suitable to use in LC/MS or GC/MS applications for clinical toxicology, forensic analysis, or urine drug testing. MDA, or 3,4-methylenedioxyamphetamine, is an illicit recreational drug of the amphetamine and phenethylamine classes. Also known as tenamphetamine, MDA is abused for its psychedelic and hallucinogenic effects, similar to those of MDMA (Ecstasy).

Aplicação

  • MDA Research Chemical: (±)-MDA solution is extensively used in scientific research to study its pharmacological properties, including its effects on neurotransmitter systems which are critical in understanding substance-related disorders.
  • MDA Enantiomers: The solution includes both enantiomers of MDA, allowing for detailed studies on the differential biological activities of each enantiomer in neuropharmacological research.
  • Synthetic MDA Solution: This synthetic solution is crucial for controlled studies in biochemistry and pharmacology, providing a consistent baseline for experimental reproducibility and validation.
  • MDA Biochemistry Application: Utilized in biochemical assays, (±)-MDA solution helps in the exploration of its metabolic pathways and interactions with biological macromolecules, enhancing the understanding of its pharmacodynamics.
  • MDA Pharmacological Studies: As a key tool in pharmacological research, (±)-MDA solution is used to investigate its potential therapeutic effects and risks, contributing to the development of safety guidelines and therapeutic protocols.

Informações legais

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

produto relacionado

Nº do produto
Descrição
Preços

Palavra indicadora

Danger

Classificações de perigo

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

Órgãos-alvo

Eyes

Código de classe de armazenamento

3 - Flammable liquids

Classe de risco de água (WGK)

WGK 1

Ponto de fulgor (°F)

49.5 °F - closed cup

Ponto de fulgor (°C)

9.7 °C - closed cup


Certificados de análise (COA)

Busque Certificados de análise (COA) digitando o Número do Lote do produto. Os números de lote e remessa podem ser encontrados no rótulo de um produto após a palavra “Lot” ou “Batch”.

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

Cédric M Hysek et al.
PloS one, 7(5), e36476-e36476 (2012-05-11)
This study assessed the effects of the serotonin (5-HT) and norepinephrine (NE) transporter inhibitor duloxetine on the effects of 3,4-methylenedioxy-methamphetamine (MDMA, ecstasy) in vitro and in 16 healthy subjects. The clinical study used a double-blind, randomized, placebo-controlled, four-session, crossover design.
Brandon J Warrick et al.
Journal of medical toxicology : official journal of the American College of Medical Toxicology, 8(1), 65-68 (2011-12-14)
A new generation of designer phenethylamines have emerged and aggressively marketed as "legal highs." The drugs are labeled "not for human consumption" to avoid widespread recognition and prosecution under the existing analog drug laws. The newest generation includes methylone and
Aixin Shi et al.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 908, 87-93 (2012-11-06)
Piperphentonamine hydrochloride (PPTA) is a new calcium sensitizer. A liquid chromatography-tandem mass spectrometry (LC/MS/MS) method for determination of piperphentonamine and its metabolites M1 and M6 was developed for the first time and applied to a pharmacokinetics study. Protein precipitation was
Juan Bin et al.
Metabolic brain disease, 27(4), 495-505 (2012-07-31)
The calcium sensitizers levosimendan and piperphentonamine hydrochloride (PPTA) are used as cardiovascular drugs for treatment of heart failure. Given that levosimendan has been reported to exhibit a neuroprotective profile in a model of traumatic brain injury, it was interesting to
Raul López-Arnau et al.
British journal of pharmacology, 167(2), 407-420 (2012-04-19)
Here, we have compared the neurochemical profile of three new cathinones, butylone, mephedrone and methylone, in terms of their potential to inhibit plasmalemmal and vesicular monoamine transporters. Their interaction with 5-HT and dopamine receptors and their psychostimulant effect was also

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica